Our findings support a future longer-term randomized control trial to look at the effects of omega 3 in reducing the incidence of lung cancer in people who are at high risk for lung cancer and have high levels (>2 mg/L) of the inflammatory marker, CRP. This evidence concerns the gene CRP and lung carcinoma.